SKYLAR MCCORMICK: Open Payments
NPI 1780355016 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 38 payments from 12 companies in 2025. Trend: 2023 $331 · 2024 $639 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $278 |
| Vanda Pharmaceuticals Inc. | 4 | $101 |
| Neurocrine BioSciences, Inc. | 5 | $92 |
| Alkermes, Inc. | 4 | $75 |
| Corium, LLC | 4 | $47 |
| Dexcom, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, FANAPT, INGREZZA, ARISTADA, Azstarys, Dexcom G6 Transmitter, Auvelity, Qelbree.
Industry payments across IL — which companies pay providers there.
